Moore Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-750,000
Closed -$7.7M – 656
2023
Q2
$7.7M Hold
750,000
– – 0.13% 124
2023
Q1
$7.59M Hold
750,000
– – 0.16% 115
2022
Q4
$7.5M Hold
750,000
– – 0.18% 110
2022
Q3
$7.27M Hold
750,000
– – 0.17% 128
2022
Q2
$7.27M Hold
750,000
– – 0.19% 122
2022
Q1
$7.31M Hold
750,000
– – 0.19% 126
2021
Q4
$7.36M Hold
750,000
– – 0.15% 148
2021
Q3
$7.37M Buy
+750,000
New +$7.41M 0.11% 179

Moore Capital Management's DALS Position: Q3 2023 in Review

Moore Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 750,000 shares — an estimated $7.7M sold.

Moore Capital Management first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $7.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Moore Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Moore Capital Management sold 750,000 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $7.7M.
  • Moore Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 8 quarters.
  • Moore Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $7.7M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Moore Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.